Almagel excluded to be used as reflux esophagitis treatment
Since the ‘reflux esophagitis’ indication of almagate drugs, including Almagel(Yuhan Corporation), has been excluded since the 17th of the last month, the relevant suspension market has been worried.
In order to fill in the vacancy of almagate drugs, which had been largely prescribed for reflux ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
